Combined therapy with dutasteride and tadalafil vs dutasteride or tadalafil monotherapy in benign prostatic hyperplasia: a randomised phase III trial.
BJU international · Apr 1, 2026
What's New: A fixed-dose combination of dutasteride and tadalafil was associated with significantly greater symptom improvement than either drug alone in men with BPH.
Read more →